COMORBID DISEASES OF THE CARDIORESPIRATORY SYSTEM IN PATIENTS AFTER CARRYING OUT COVID-19
Keywords:
COVID-19, cardiorespiratory system, comorbidityAbstract
In the world, research work is underway to study the pathogenesis, clinical features of a new coronavirus infection and the development of methods for effective treatment and rehabilitation measures. Along with damage to the lung tissue, a number of observations revealed changes in other organs, including the type of vasculitis. Many studies in the world are aimed at finding mechanisms for the development of post-COVID syndrome, the development of rehabilitation measures that will reduce the risk of disability and mortality in patients [4]. In this regard, the study of the clinical and pathogenetic features of the early rehabilitation period of COVID-19 and the determination of the optimal tactics for managing patients, taking into account the nature of the disorders, is an urgent problem of modern medicine. The peculiarities of the course of comorbid diseases of the cardiorespirative system in patients after COVID-19 were studied. It was established that the most common diseases were diseases of the cardiovascular system.
References
Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. и др. Международный регистр “Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 ^КТИВ SARS-CoV-2)”: анализ 1000 пациентов. Российский кардиологический журнал. 2020;25(11):4165. https://doi.org/10.15829/1560-4071-2020-4165.
Баздырев Е.Д. Коронавирусная инфекция – актуальная проблема XXI века. Комплексные проблемы сердечно-сосудистых заболеваний. 2020; 9(2) :6-16.
Верткин А.Л., Авдеев С.Н., Ройтман Е.В., Сучков А. Вопросы лечения COVID-19 с позиции коррекции эндотелиопатии и профилактики тромботических осложнений. Согласованная позиция экспертов. // Профилактическая медицина. 2021;24(4):45 51.
Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.
COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence review 5: interventions. London: National Institute for Health and Care Excellence (UK). NICE Guideline 2020;(188). Available from: https://www.ncbi.nlm.nih.gov/books/NBK567264
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU nvestigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60-73.
Günster C, Busse R, Spoden M, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS One. 2021;16(8):e0255427.
Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-32.
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020 Dec;69(12):1181-1189.
Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8(9):853-62.
Lippi G, Henry BM. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir Med. 2020;167:105941.
Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation 2020;142:68-78.
Natural History of PostCoronavirus Disease 19 Convalescence at the National Institutes of Health. 2020. ClinicalTrials.gov Identifier: NCT04573062
World Health Organization (WHO). https://www.who.int.
